AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.59) per share. This is a 82.39 percent increase over losses of $(3.35) per share from the same period last year.
Novo Nordisk Q4 EPS $0.81 Misses $0.85 Estimate, Sales $6.44B Miss $6.84B Estimate
Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.81 per share which missed the analyst consensus estimate of $0.85 by 4.71 percent. This is a 10.96 percent increase over earnings of $0.73 per share from the same
